These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7543954)

  • 21. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.
    Linch DC; Scarffe H; Proctor S; Chopra R; Taylor PR; Morgenstern G; Cunningham D; Burnett AK; Cawley JC; Franklin IM
    Bone Marrow Transplant; 1993 Apr; 11(4):307-11. PubMed ID: 7683552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
    Takeyama H; Kajiguchi T; Miyata Y; Saito M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution.
    Calderwood S; Doyle JJ; Hitzler JK; Saunders EF; Freedman MH
    Bone Marrow Transplant; 1996 Jul; 18(1):87-91. PubMed ID: 8832000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL; Berti P
    Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino S; Morioka M; Irie T; Shiroshita N; Kawamura T; Suzuki S; Iwasaki H; Umehara S; Kakinoki Y; Kurosawa M; Kahata K; Izumiyama K; Kobayashi H; Onozawa M; Takahata M; Fujisawa F; Kondo T; Asaka M
    Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia.
    Shang X; Yin H; Lu A; Zhang L
    Chin Med J (Engl); 1999 Jul; 112(7):620-2. PubMed ID: 11601256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
    Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effect of dolichyl phosphate and human recombinant granulocyte colony-stimulating factor on recovery from neutropenia in mice treated with anti-cancer drugs.
    Shimamura M; Takigawa T; Urabe A; Okabe T; Souza LM; Takaku F
    Exp Hematol; 1988 Sep; 16(8):681-5. PubMed ID: 2456942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A phase III trial of subcutaneous administration of rhG-CSF in aplastic anemia].
    Yoshida Y; Okuma M; Suzuki T; Takahashi T; Nakagawa M; Kashima K; Abe T; Sonoda Y; Fujii H; Haruyama H
    Rinsho Ketsueki; 1994 Nov; 35(11):1282-8. PubMed ID: 7529841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complete remission in acute myeloblastic leukemia (M0) after treatment with rhG-CSF].
    Maeda A; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takano K; Harakawa N; Nakabo Y; Takahashi A; Yamamoto K
    Rinsho Ketsueki; 1995 Jan; 36(1):45-9. PubMed ID: 7536276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor.
    Calhoun DA; Lunøe M; Du Y; Hutson AD; Veerman M; Christensen RD
    Pediatrics; 2000 Feb; 105(2):392-7. PubMed ID: 10654961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.
    Usuki K; Urabe A; Masaoka T; Ohno R; Mizoguchi H; Hamajima N; Miyazaki T; Niitsu Y; Yoshida Y; Miura A; Shibata A; Abe T; Miura Y; Ikeda Y; Nomura T; Nagao T; Saitou H; Shirakawa S; Ohkuma M; Matsuda T; Nakamura T; Horiuchi A; Kuramoto A; Kimura I; Irino S; Niho Y; Takatsuki K; Tomonaga M; Uchino H; Takaku F;
    Br J Haematol; 2002 Jan; 116(1):103-12. PubMed ID: 11841402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Colony stimulating factors in blood formation].
    Goebel M
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():51-6. PubMed ID: 7531048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous eruptions induced by granulocyte colony-stimulating factor in two cases of acute myelogenous leukemia.
    Yamashita N; Natsuaki M; Morita H; Kitano Y; Sagami S
    J Dermatol; 1993 Aug; 20(8):473-7. PubMed ID: 7504005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.